Delivery Order SPE2DB22D1103-SPE2DB24FTFC6
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,319,446 units of 2 mg glimepiride tablets. The $1,728.22 award has a completion date of January 16, 2024 and was made on January 12, 2024. This delivery order is part of a larger indefinite delivery contract held by AmerisourceBergen Drug Corp to provide pharmaceuticals and medical supplies to DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,451.03 firm fixed price delivery order is for the supply of 4564000979 - GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 19, 2024 and does not have any set-aside designation....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Glimepiride 4 mg tablets. The $1,872.20 contract has a performance period through March 12, 2024. AmerisourceBergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The firm-fixed-price contract has a ceiling value of $7,264.63 and a completion date of September 5, 2024. There is no set-aside designation for this award. Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4 mg Glimepiride tablets. The $1,018.49 fixed-price contract has an April 2024 completion date and is not a set-aside. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medications and medical supplies to various federal agencies, with a focus on supporting the Department of Defense (DoD) and Veterans...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Glimepiride 4 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,126.05 under firm fixed price terms, with an ultimate completion date of September 9, 2025. The delivery order was issued on September 8, 2025, and will be performed at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,282.04 firm fixed price delivery order is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a pharmaceutical product. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $7,926.54 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 Glimepiride 4 mg tablets. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 4, 2023. No set aside designation was applied to this order, which was issued against an indefinite delivery contract held by Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,625.36 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of 4565392018 - GLIMEPIRIDE 2 MG TABLET 500S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of medical...
- This is a $5,238.22 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is for the delivery of GLIMEPIRIDE 4 MG TABLET 100S, a medication used to treat diabetes. The contract has an ultimate completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFC6Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of GLIMEPIRIDE 4 MG TABLET 100S. The contract has a total potential value of $12,852.36 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will perform the work from its Corporate Office location in Conshohocken, Pennsylvania. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 2/12/24 |